A New Method to Induce Nonalcoholic Steatohepatitis (NASH) in Mice

BMC Gastroenterology - United Kingdom
doi 10.1186/s12876-019-1041-x
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Effects of Bezafibrate to High Trans-Fat Diet (HTD) -Induced Nonalcoholic Steatohepatitis (NASH) Model in Mice

Proceedings for Annual Meeting of The Japanese Pharmacological Society
2020English

Cyclophilin Inhibition as a Potential Treatment for Nonalcoholic Steatohepatitis (NASH)

Expert Opinion on Investigational Drugs
MedicinePharmacology
2019English

Lipidomic and Transcriptomic Analysis of Western Diet-Induced Nonalcoholic Steatohepatitis (NASH) in Female LDLR -/- Mice

PLoS ONE
Multidisciplinary
2019English

Molecular Pathogenesis of Nonalcoholic Steatohepatitis- (NASH-) Related Hepatocellular Carcinoma

Canadian Journal of Gastroenterology and Hepatology
MedicineHepatologyGastroenterology
2018English

The Histone Methyltransferase Suv39h2 Contributes to Nonalcoholic Steatohepatitis in Mice

Hepatology
MedicineHepatology
2017English

Letter: Clinical Response to Pioglitazone in Nonalcoholic Steatohepatitis [NASH] Treatment-Use of Pharmacokinetic Surrogate

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Mouse Models of Nonalcoholic Steatohepatitis Towards Optimization of Their Relevance to Human NASH

Hepatology
MedicineHepatology
2019English

New Clinical Score to Diagnose Nonalcoholic Steatohepatitis in Obese Patients

Diabetology and Metabolic Syndrome
Internal MedicineEndocrinologyMetabolismDiabetes
2011English

Nonalcoholic Steatohepatitis

English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy